⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with active psoriatic arthritis and obesity or overweight
prnewswire.com
LLY
WORLDLINE : EGM results - Press release
globenewswire.com
JPM
BAC
WFC
MS
GS
AXP
PYPL
V
MA
CMCSA
T
VZ
IBM
ORCL
SAP
ACN
ADP
PAYX
FIS
FDS
EVO
PSFE
LCID
RIVN
NIO
XPEV
TSLA
GM
F
STLA
CRDO
ADBE
GOOG
AMZN
META
NVDA
INTC
AMD
QCOM
CRM
NFLX
DIS
CMG
MCD
SBUX
PEP
KO
PG
JNJ
PFE
MRK
ABBV
AMGN
GILD
BMY
LLY
UNH
CVS
XOM
CVX
SHEL
BABA
JD
PDD
NTES
BIDU
AMTD
CPT
CA
BP
Ray Therapeutics Appoints Scott Braunstein, M.D., as Chairman of the Board of Directors
businesswire.com
PCAR
ESPR
PRTA
LLY
CRBU
RAPT
Benchling and Lilly TuneLab Partner to Democratize Access to AI Models for Scientists Everywhere
prnewswire.com
LLY
MRK
MRNA
SNY
NVDA
Recludix Pharma Bolsters Scientific Advisory Board with Acclaimed Leaders in the Fields of Rheumatology, Dermatology and JAK/STAT Biology
globenewswire.com
SCLZ
LLY
SNY
$21.93 Bn Colorectal Cancer Drugs Global Market Trends, Opportunities and Strategies, 2019-2024, 2025-2029F, 2034F
globenewswire.com
MRK
AMGN
BMY
LLY
TAK
PFE
SNY
Psoriasis Market to Exhibit Growth at a CAGR of 1.7% During the Forecast Period (2025-2034), Owing to Continuous Innovation in Biologic Therapies and Approval of Oral Small Molecules | DelveInsight
prnewswire.com
TAK
JNJ
CANF
AMGN
ABBV
NVS
BMY
AZN
BHC
LLY
UCB
LEO
REGN
XBI
IBB
JAZZ
MRK
SNY
GILD
INCY
PFE
LULU
PRTH
DRH
BIIB
TEVA
ARCT
HRMY
CRSP
NTLA
EDIT
SNOW
DDOG
CRM
GOOG
MSFT
AAPL
AMZN
TSLA
NVDA
META
NFLX
DIS
CMCSA
VZ
T
KO
PEP
MCD
SBUX
HD
EXAS
ILMN
BNTX
MRNA
XOM
CVX
BA
CAT
GE
IBM
INTC
CSCO
ADBE
QCOM
AMAT
MU
ORCL
ACN
COST
WMT
TGT
LOW
HON
GD
LMT
RTX
BAX
Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases
prnewswire.com
LLY
VTYX
Ametris reports significant momentum with global pharma leaders
businesswire.com
LLY
AZN
InduPro Therapeutics Announces Strategic Collaboration with Lilly to Develop First-in-Class Bispecific/Multispecific Oncology Therapeutics Using InduPro’s Proximity-Guided Platform
businesswire.com
LLY